
|Articles|July 14, 2022
Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids
Author(s)Miranda Hester
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Journal Digest: September 2, 2026
3
Dermatology Times Launches Derm Nexus Congress for NPs and PAs
4
Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis
5







